| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.21 | 0.0007 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.073 | 0.2 |